KELLEY SCOTT 4
4 · Flexion Therapeutics Inc · Filed Dec 22, 2017
Insider Transaction Report
Form 4
KELLEY SCOTT
Chief Medical Officer
Transactions
- Other
Common Stock
2017-12-20$16.59/sh+858$14,234→ 6,559 total
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 858 shares by the Reporting Person on December 20, 2017 pursuant to the Issuer's Employee Stock Purchase Plan.